How long can patients with mild or moderate Alzheimer’s dementia maintain both the cognition and the therapy of cholinesterase inhibitors: a national population-based study-Reference-Cited by-同舟云学术

How long can patients with mild or moderate Alzheimer’s dementia maintain both the cognition and the therapy of cholinesterase inhibitors: a national population-based study

Published:2008-03 Issue:3 Volume:15 Page:278-283
ISSN:1351-5101
Container-title:European Journal of Neurology
language:en
Short-container-title:Eur J Neurol

Author:

Sun Y.,Lai M.-S.,Lu C.-J.,Chen R.-C.

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1468-1331.2007.02049.x/fullpdf

Reference37 articles.

1. Determinants of costs of care for patients with Alzheimer's disease

2. Economic Aspects on Drug Therapy of Dementia

3. Pharmacoeconomics of cholinesterase inhibitors in the treatment of Alzheimer’s disease

4. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer

5. Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Co-activation of selective nicotinic acetylcholine receptor subtypes is required to reverse hippocampal network dysfunction and prevent fear memory loss in Alzheimer’s disease;2024-07-11

2. Biomarkers in Alzheimer’s Disease: Are Olfactory Neuronal Precursors Useful for Antemortem Biomarker Research?;Brain Sciences;2024-01-02

3. α‐bisabolol β‐d‐fucopyranoside (ABFP) ameliorates scopolamine‐induced memory deficits through cholinesterase inhibition and attenuation of oxidative stress in zebrafish (Danio rerio);Journal of Biochemical and Molecular Toxicology;2023-11-14

4. The association between acupuncture therapy and the risk of reduced pressure ulcers in dementia patients: A retrospective matched cohort study;Integrative Medicine Research;2023-09

5. Insights into the Role of Erythrina corallodendron L. in Alzheimer's Disease: in Vitro and in Silico Approach;Chemistry & Biodiversity;2023-07